Early Predictor Tool of Disease Using Label-Free Liquid Biopsy-Based Platforms for Patient-Centric Healthcare
Cancer cells undergo phenotypic changes or mutations during treatment, making detecting protein-based or gene-based biomarkers challenging. Here, we used algorithmic analysis combined with patient-derived tumor models to derive an early prediction tool using patient-derived cell clusters from liquid...
Main Authors: | Wei Li, Yunlan Zhou, Yanlin Deng, Bee Luan Khoo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-02-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/3/818 |
Similar Items
-
The functional and clinical roles of liquid biopsy in patient-derived models
by: Ziqing Zhu, et al.
Published: (2023-04-01) -
Variations on a theme: Labeling patients as persons, the nursed, or client in nursing
by: Feni Betriana, et al.
Published: (2022-12-01) -
Recent Advances in the Label-Free Characterization of Exosomes for Cancer Liquid Biopsy: From Scattering and Spectroscopy to Nanoindentation and Nanodevices
by: Riccardo Di Santo, et al.
Published: (2021-06-01) -
Identification of specimen labeling errors in pathology specimens received from different wards of the hospital: A patient safety approach
by: Seyed Saeed Tabatabaee, et al.
Published: (2020-09-01) -
Patient-reported outcomes labeling for oncology drugs: Multidisciplinary perspectives on current status and future directions
by: David Cella, et al.
Published: (2022-10-01)